Department of Biochemistry and Molecular Biology, Institute of Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Jerusalem, Israel.
PLoS One. 2013 May 15;8(5):e62948. doi: 10.1371/journal.pone.0062948. Print 2013.
Cardiovascular dysfunction is a major complication of diabetes. Examining mechanistic aspects underlying the incapacity of the diabetic heart to respond to ischemic preconditioning (IPC), we could show that the alterations in iron homeostasis can explain this phenomenon. Correlating the hemodynamic parameters with levels of ferritin, the main iron storage and detoxifying protein, without and with inhibitors of protein degradation, substantiated this explanation. Diabetic hearts were less sensitive to ischemia-reperfusion stress, as indicated by functional parameters and histology. Mechanistically, since ferritin has been shown to provide cellular protection against insults, including ischemia-reperfusion stress and as the basal ferritin level in diabetic heart was 2-fold higher than in controls, these are in accord with the greater resistance of the diabetic heart to ischemia-reperfusion. Additionally, during ischemia-reperfusion, preceded by IPC, a rapid and extensive loss in ferritin levels, during the prolonged ischemia, in diabetic heart but not in non-diabetic controls, provide additional substantiation to the explanation for loss of respond to IPC. Current research is shedding light on the mechanism behind ferritin degradation as well, suggesting a novel explanation for diabetes-induced loss of cardioprotection.
心血管功能障碍是糖尿病的主要并发症。为了研究糖尿病心脏对缺血预处理(IPC)反应能力丧失的机制,我们发现铁稳态的改变可以解释这一现象。通过比较铁蛋白(主要的铁储存和解毒蛋白)的水平及其降解抑制剂,将血流动力学参数与铁蛋白水平相关联,进一步证实了这一解释。糖尿病心脏对缺血再灌注应激的敏感性降低,这可以通过功能参数和组织学来判断。从机制上讲,由于铁蛋白已被证明可以提供对包括缺血再灌注应激在内的各种损伤的细胞保护,并且糖尿病心脏的基础铁蛋白水平是对照组的两倍,因此这些与糖尿病心脏对缺血再灌注的更强抵抗力是一致的。此外,在缺血预处理之前的缺血再灌注期间,铁蛋白水平迅速且广泛下降,在糖尿病心脏中,但在非糖尿病对照组中,这种下降在延长的缺血期间并没有发生,这为 IPC 反应丧失提供了更多的证据。目前的研究也揭示了铁蛋白降解背后的机制,为糖尿病引起的心脏保护丧失提供了新的解释。